Cross Keys Capital is a leading middle-market investment bank providing a full range of investment banking merger and acquisition advisory services to a variety of businesses nationally.

The ability to restore light responses in human retinas postmortem offers a novel model for studying retinal recovery and ...

The launch was attended by Shamsheer Vayalil, Chairman and Chief Executive Officer of Burjeel Holdings, Khaled Ateeq ...

Population penetrance of inherited retinal degeneration variants is significantly lower than was previously believed.

Congenital stationary night blindness (CSNB) is caused by mutations in a specific calcium channel. A comprehensive proteomic study by researchers at the University of Innsbruck now reveals how these ...

Topic: Opus Genetics leadership will participate in discussions focused on emerging treatment approaches and clinical insights in retinal disease. Topic: The Company will engage with the global ...

Endocrine disorders, particularly diabetes mellitus, represent a growing global health burden with far-reaching systemic consequences. Beyond classic ...

The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...

Tenecteplase failed to outperform aspirin for vision recovery when administered within 4.5 hours of onset of acute central ...

Visual disorders, particularly myopia, have become a significant public health concern among adolescents globally, with prevalence rates soaring in recent ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering ...